Anastasios Giannou

Anastasios Giannou is a Professor affiliated with the Medizinische Fakultät at Universität Hamburg, likely within the Department of Surgery or Immunology/Oncology. His research focuses on immunological mechanisms in cancer metastasis, cytokine biology, and translational oncology. He has contributed significantly to understanding tumor-immune interactions, particularly the roles of IL-10, IL-22, and regulatory T cells in promoting metastasis. His work integrates preclinical models with clinical insights, addressing challenges in solid organ transplantation tolerance and pancreatic/gastrointestinal cancers. Giannou has published extensively on topics such as microbiota-drug interactions in chemotherapy efficacy, developmental biology of pancreatic dysfunction, and mechanistic links between inflammation and tumorigenesis.

His articles highlight interdisciplinary approaches, combining immunology, molecular biology, and oncology to explore pathways like TGF-β signaling in Th17 cells and IL-22BP regulation in liver metastasis. Experimental models include mouse orthotopic transplantations and in vitro systems to study metastatic progression. Giannou’s work bridges basic science and clinical applications, aiming to improve therapeutic strategies for cancer and inflammatory diseases.